-
Japan protests Putin's first visit to disputed islands
-
Hasan takes 6-55 as Bangladesh bundle out Australia for 198
-
Kiss wants fit-again Wallabies playmaker Gordon to 'open up' Japan
-
Swiatek sinks Svitolina to set up Rybakina title clash in Toronto
-
British eccentrics push humble garden shed to new heights
-
Australia's Pallister shines, mixed relay record falls as Pan Pacs open
-
Zambia votes with president's economic record on the line
-
Hasan puts Bangladesh in charge as Australia struggle to 183-8
-
Germany's dry rivers spark battle on engineering vs restoration
-
Putin visits Kuril islands claimed by Japan
-
Senators demand inquiry into conditions aboard USS Abraham Lincoln
-
Swiatek downs Svitolina to reach first WTA final of 2026
-
All Blacks' Proctor out of South Africa series, Mo'unga called up
-
Jones says Japan 'watching videos of geese' for Australia clash
-
Bangladesh quick Hasan reduces Australia to 74-4 at lunch
-
Bloodied but unbowed, defending champ Shelton reaches Montreal final
-
Seoul tech leads Asian stock gains as traders cheer US inflation
-
Wallabies make eight changes for return Japan Test
-
Farage and Count Binface go head-to-head in snap UK poll
-
Messi returns after father's death but Miami knocked out of Leagues Cup
-
Afghan students divided over smartphone ban at universities
-
Outflanked by AI, stars fade for South Korea's blind fortune-tellers
-
Japan go back to school for second Australia Test
-
Venezuela govt, opposition wrap up round of post-Maduro talks
-
Matthew McConaughey on his sweet return to the big screen
-
Five things to know about Zambia as it goes to the polls
-
President's economic record on the line as Zambia votes
-
Nakashima holds off Jodar to book first ATP Masters final in Montreal
-
Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
-
Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 13
-
Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
-
3 Home Repairs You Can't Afford to Put Off
-
Grieving Messi available for Miami in Leagues Cup clash
-
Trump 'low-key' bets on economic pressure against Iran
-
Colombia enters 'final phase' of quake search as toll hits 265
-
Pitch invaders take selfies with Fernandes during Man Utd friendly
-
Father-figure Christie helps guide Kounta to European silver
-
No-stress Sabalenka won't fret over lackluster 2026 results
-
McIlroy returns to St. Jude to launch marathon PGA playoff push
-
Hometown hero Hudson-Smith basks in Euro glory
-
Guimaraes makes Arsenal debut in Como friendly
-
PSG down Aston Villa to retain UEFA Super Cup
-
Travis Kelce says wedding to Taylor Swift was 'best night of my life'
-
Trump's spokesperson Karoline Leavitt to step down
-
US stocks mostly up after data shows slightly lower inflation in July
-
'Imposing ignorance': US climate science under siege
-
Caracas protest denounces secrecy of Venezuela transition talks
-
As millions gazed in awe, a swathe of Spain plunged into darkness
-
Hudson-Smith regains Euro 400m title on home track
Australia doctors warn of 'excessive' medical weed prescriptions
Australia's medical cannabis industry is "excessively" prescribing weed with little oversight and needs urgent regulation, the country's top doctors association and pharmacists warned on Tuesday.
Legalised for medical use in 2016, Australians are estimated to have spent up to $500 million on licit pot last year, according to a think tank.
But on Tuesday the Australian Medical Association (AMA) and the Pharmacy Guild of Australia said the industry was too often issuing prescriptions without "proper clinical oversight".
"Urgent action is needed to ensure medicinal cannabis is prescribed, dispensed and regulated in the same manner as other registered drugs of dependence," AMA President Danielle McMullen said.
While acknowledging evidence suggesting medical cannabis can help treat epilepsy, chemotherapy-induced nausea or Multiple Sclerosis, doctors warned the system was being "exploited".
"There is little, or no evidence base for many of the conditions for which it is being prescribed, such as anxiety, insomnia or depression," McMullen said.
In their submission to an Australian government inquiry into the industry, the AMA called for "comprehensive reform" of the way medical cannabis was bought and sold.
Members working in emergency departments were calling for more resources to deal with growing numbers of patients with cases related to excessive intake of cannabis, including psychosis, they said.
"Alarmingly, doctors are seeing medicinal cannabis use in people who have pre-existing psychotic conditions," they warned.
The AMA warned telehealth models -- in which patients can be issued prescriptions online without an in-person doctor visit -- were being "exploited as commercial pathways for unapproved products".
This year, newspaper the Age revealed that one doctor working for medical cannabis giant Montu had issued 72,000 prescriptions to 10,000 patients in just two years.
In some instances, the newspaper reported, consultations with patients were scheduled to last no longer than 10 minutes.
The global medical cannabis market is expected to grow to over $65 billion by 2030, according to consulting firm Grand View Research.
E.Hall--AT